These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow. Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024 [TBL] [Abstract][Full Text] [Related]
26. Expression of CCL3 by neoplastic cells in patients with Waldenström's macroglobulinemia: an immunohistochemical study in bone marrow biopsies of 67 patients. Terpos E; Tasidou A; Eleftherakis-Papaiakovou E; Christoulas D; Gavriatopoulou M; Gkotzamanidou M; Roussou M; Kastritis E; Papadaki T; Dimopoulos MA Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):115-7. PubMed ID: 21454208 [TBL] [Abstract][Full Text] [Related]
27. Bone-marrow plasma cell burden correlates with IgM paraprotein concentration in Waldenstrom macroglobulinaemia. Pasricha SR; Juneja SK; Westerman DA; Came NA J Clin Pathol; 2011 Jun; 64(6):520-3. PubMed ID: 21471142 [TBL] [Abstract][Full Text] [Related]
28. Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients. Lin P; Bueso-Ramos C; Wilson CS; Mansoor A; Medeiros LJ Am J Surg Pathol; 2003 Aug; 27(8):1104-13. PubMed ID: 12883242 [TBL] [Abstract][Full Text] [Related]
29. Sudden unexpected death after initial infusion of rituximab for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma: an autopsy case. Ichimata S; Hata Y; Nomoto K; Sato T; Nishida N Diagn Pathol; 2024 Jun; 19(1):89. PubMed ID: 38943126 [TBL] [Abstract][Full Text] [Related]
30. [The pathology and genetic background of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia]. Timár B Magy Onkol; 2017 Mar; 61(1):6-11. PubMed ID: 28273183 [TBL] [Abstract][Full Text] [Related]
31. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma. Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885 [TBL] [Abstract][Full Text] [Related]
32. Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation. Walsh SH; Laurell A; Sundström G; Roos G; Sundström C; Rosenquist R Leuk Res; 2005 Jul; 29(7):729-34. PubMed ID: 15927667 [TBL] [Abstract][Full Text] [Related]
33. Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations. Treon SP; Kelliher A; Keele B; Frankel S; Emmanouilides C; Kimby E; Schlossman R; Mitsiades N; Mitsiades C; Preffer F; Anderson KC Semin Oncol; 2003 Apr; 30(2):248-52. PubMed ID: 12720146 [TBL] [Abstract][Full Text] [Related]
34. [Therapeutic algorithm of Waldenström's macroglobulinemia or lymphoplasmacytic lymphoma in Japan]. Sekiguchi N Rinsho Ketsueki; 2021; 62(8):1139-1148. PubMed ID: 34497201 [TBL] [Abstract][Full Text] [Related]
35. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with Hodgkin disease. A report of two cases. Rosales CM; Lin P; Mansoor A; Bueso-Ramos C; Medeiros LJ Am J Clin Pathol; 2001 Jul; 116(1):34-40. PubMed ID: 11447749 [TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry. Ocio EM; del Carpio D; Caballero Á; Alonso J; Paiva B; Pesoa R; Villaescusa T; López-Anglada L; Vidriales B; García-Sanz R Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):93-5. PubMed ID: 21454201 [TBL] [Abstract][Full Text] [Related]
37. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression. Amaador K; Vos JMI; Pals ST; Kraan W; Dobber JA; Minnema MC; Koene HR; de Bruin PC; Zwinderman AH; Kersten MJ Leuk Lymphoma; 2022 May; 63(5):1070-1079. PubMed ID: 34961399 [TBL] [Abstract][Full Text] [Related]
38. Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy. Barakat FH; Medeiros LJ; Wei EX; Konoplev S; Lin P; Jorgensen JL Am J Clin Pathol; 2011 Mar; 135(3):365-73. PubMed ID: 21350089 [TBL] [Abstract][Full Text] [Related]
39. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma. Ocio EM; Hernandez JM; Mateo G; Sanchez ML; Gonzalez B; Vidriales B; Gutierrez NC; Orfao A; San Miguel JF Clin Lymphoma; 2005 Mar; 5(4):241-5. PubMed ID: 15794856 [TBL] [Abstract][Full Text] [Related]
40. Coexistent adrenal diffuse large B cell lymphoma in a patient with Waldenström's macrogloblinemia/lymphoplasmacytic lymphoma. Shingaki S; Yoshiki Y; Yamamoto K; Ota Y; Suzuki K Ann Hematol; 2016 Oct; 95(10):1723-4. PubMed ID: 27365139 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]